| Literature DB >> 29440588 |
Phil A Crosbie1,2, Haval Balata1, Matthew Evison1, Melanie Atack3, Val Bayliss-Brideaux3, Denis Colligan3,4, Rebecca Duerden1, Josephine Eaglesfield3, Timothy Edwards1, Peter Elton5, Julie Foster6, Melanie Greaves1, Graham Hayler3, Coral Higgins4, John Howells7, Klaus Irion8, Devinda Karunaratne8, Jodie Kelly1, Zoe King3, Sarah Manson1, Stuart Mellor9, Donna Miller10, Amanda Myerscough3, Tom Newton9, Michelle O'Leary11, Rachel Pearson3,4, Julie Pickford6, Richard Sawyer1, Nick J Screaton12, Anna Sharman1, Maggi Simmons3, Elaine Smith1, Ben Taylor13, Sarah Taylor3,4, Anna Walsham14, Angela Watts1, James Whittaker15, Laura Yarnell3,4, Anthony Threlfall3, Phil V Barber1, Janet Tonge3,4, Richard Booton1.
Abstract
We report baseline results of a community-based, targeted, low-dose CT (LDCT) lung cancer screening pilot in deprived areas of Manchester. Ever smokers, aged 55-74 years, were invited to 'lung health checks' (LHCs) next to local shopping centres, with immediate access to LDCT for those at high risk (6-year risk ≥1.51%, PLCOM2012 calculator). 75% of attendees (n=1893/2541) were ranked in the lowest deprivation quintile; 56% were high risk and of 1384 individuals screened, 3% (95% CI 2.3% to 4.1%) had lung cancer (80% early stage) of whom 65% had surgical resection. Taking lung cancer screening into communities, with an LHC approach, is effective and engages populations in deprived areas. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: lung cancer
Mesh：
Year: 2018 PMID： 29440588 DOI： 10.1136/thoraxjnl-2017-211377
Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139